Exuberant Plexiform Neurofibroma.
Correia C, Reis M, Filipe P.
Acta Med Port. 2023 Dec 4;36(12):846-847. doi: 10.20344/amp.19477. Epub 2023 May 19.
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
Kershner LJ, Choi K, Wu J, Zhang X, Perrino M, Salomonis N, Shern JF, Ratner N.
JCI Insight. 2022 Sep 22;7(18):e154513. doi: 10.1172/jci.insight.154513.
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.
Kim H, Yoon HM, Kim EK, Ra YS, Kim HW, Yum MS, Kim MJ, Baek JS, Sung YS, Lee SM, Lim HS, Lee BJ, Lim HT, Kim D, Yoon J, Bae H, Hwang S, Choi YH, Kim KA, Choi IH, Lee SW, Park SJ, Lee BH.
Neuro Oncol. 2024 Dec 5;26(12):2352-2363. doi: 10.1093/neuonc/noae121.
Plexiform neurofibroma of the uterus.
Rogers D.
Arch Gynecol Obstet. 2022 Feb;305(2):535-536. doi: 10.1007/s00404-021-06341-y. Epub 2021 Nov 28.
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
Gross AM, Glassberg B, Wolters PL, Dombi E, Baldwin A, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Whitcomb P, Paul SM, Steinberg SM, Venzon DJ, Martin S, Carbonell A, Heisey K, Therrien J, Kapustina O, Dufek A, Derdak J, Smith MA, Widemann BC.
Neuro Oncol. 2022 Nov 2;24(11):1978-1988. doi: 10.1093/neuonc/noac109.
Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.
Staser K, Yang FC, Clapp DW.
Curr Opin Hematol. 2010 Jul;17(4):287-93. doi: 10.1097/MOH.0b013e328339511b.
Plexiform neurofibroma.
Bakshi SS.
Cleve Clin J Med. 2016 Nov;83(11):792. doi: 10.3949/ccjm.83a.16002.
Challenging Management of Plexiform Schwannoma and Plexiform Neurofibroma.
Nicoli TK, Saat R, Tarkkanen J, Kinnunen I, Mäkitie AA, Jero J.
J Craniofac Surg. 2022 May 1;33(3):803-808. doi: 10.1097/SCS.0000000000008381. Epub 2021 Dec 2.
Plexiform neurofibromas.
Korf BR.
Am J Med Genet. 1999 Mar 26;89(1):31-7. doi: 10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w.
Selumetinib use as targeted therapy for plexiform neurofibroma: a comprehensive review of the literature.
Alotaibi HA, Yuen HK, Alshaibani AK, Alibrahim EA.
Orbit. 2025 Aug;44(4):478-485. doi: 10.1080/01676830.2025.2470989. Epub 2025 Feb 28.
